Peptides: State-of-Art and Commercialisation Hurdles
Closes 11 June, 2024
Issue Pre-order formJournal: Current Proteomics
Guest editor(s):Dr. Othman Al Musaimi,
Introduction
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, mitigation strategies for in vivo delivery, ongoing and planned clinical trials to date, and commercialization.
Keywords
Peptides, drug delivery, drug approvals, pharmaceuticals, oral delivery, clinical trials